PROACT is a Prospective Master Protocol for a Cohort Study Focused on Evaluating the Implementation of Integrated Proactive Supportive Care Pathways at Gustave Roussy

The primary study endpoint of PROACT is patient distress and supportive care needs (NCCN Distress Thermometer and NCCN Problem list) over a 12-week period after the supportive care needs assessment and referrals in the context of a PROACT pathway.

Secondary study endpoints include:

1. To evaluate the Reach of each pathway through the number of patients who participated in supportive care needs' assessment and in each supportive care intervention (administrative review of attendance log) 2. To evaluate the diversity of patients included in each pathways through evaluation of sociodemographic and economic profile (Socioeconomic and demographic self-reported questionnaire) 3. To evaluate the impact of each pathway and each supportive care intervention on patient's overall health status (EQ-E5-EL) 4. To evaluate the impact of each pathway and each supportive care intervention on patient's quality of life (EORTC QLQ C30) 5. To evaluate the impact of each pathway and each supportive care intervention on symptom burden (MDASI) 6. To evaluate the impact of each pathway and each supportive care intervention on anxiety (HADS) 7. To evaluate the impact of each pathway and each supportive care intervention on Insomnia levels (ISI) 8. To evaluate the impact of each pathway and each supportive care intervention on sexual health (EORTC SHQ-C22) 9. To evaluate the Physician's Adoption of each pathway through the proportion of physicians referring patients to the pathways (referral log) 10. To evaluate patient's adoption through the proportion of patients adhering to supportive care interventions as intended (attendance log) 11. To evaluate patient experience and satisfaction with the pathways (PACIC and adhoc satisfaction questionnaires. 12. To evaluate implementation in through a qualitative analyses of experience, implementation barriers and facilitators (focus groups with patients and providers) 13. To plan for Maintenance of the pathway through a cost effectiveness analysis. 14. To evaluate the impact of each pathway and each supportive care intervention on Intestinal Symptoms (LARS score). if indicated for the specific population 15. To evaluate the impact of each pathway and each supportive care intervention on Anal Incontinence (Wexner score). if indicated for the specific population 16. To evaluate the impact of each pathway and each supportive care intervention on Urinary Symptoms (USP score). if indicated for the specific population 17. To evaluate the impact of each pathway and each supportive care intervention on Hematologic Cancer (FACT-BMT) 18. To evaluate the impact of each pathway and each supportive care intervention on Montgomery Borgatta Caregiver Burden Scale. if indicated for the specific population. 19. To evaluate the healthcare professionals participating in the pathway to screen vulnerability and prevent treatment related burden (F-SUS)

This is a master protocol study that is conducted by collecting sub-studies for each supportive care intervention which share key design components and operational aspects leading to a higher level of coordination than the one achieved by independently conducted studies.

Methodology: it is a mix of quantitative and qualitative methods to assess the Reach, Efficacy and potential for Adoption, while identifying barriers to Implementation and strategies to Maintain the pathway in the institution guided by the RE-AIM framework. Data collection will allow evaluation in a macro level (integrated supportive care pathway including supportive care needs assessment and tailored multidisciplinary referrals) and in a micro level (separated for each supportive care intervention).

• Reach of the pathway [Срок оценки: week 12]
• Diversity of pathway participants [Срок оценки: week 12]
• Impact of the pathway in overall health status [Срок оценки: week 12, and 24]
• Impact of the pathway in Quality of life [Срок оценки: week 12, and 24]
• Impact of the pathway in symptom burden [Срок оценки: week 12, and 24]
• Impact of the pathway on anxiety levels [Срок оценки: week 12, and 24]
• Impact of the pathway on insomnia levels [Срок оценки: week 12, and 24]
• Impact of the pathway on sexual health [Срок оценки: week 12, and 24]
• Adoption of Physician [Срок оценки: week 12]
• Adoption of Patient [Срок оценки: week 12]
• Patient Experience [Срок оценки: week 12]
• Patient Satisfaction with the pathway [Срок оценки: week 12]